11-22

Bidding Announcement for Foundation Treatment of North District Construction Project of Sichuan Deebio Pharmaceutical Co., Ltd.In accordance with the construction progress of the N…

04-03

Sichuan Deebio Pharmaceutical Co., Ltd.Sichuan Deebio API Production Upgrade and Technical Transformation ProjectEnvironmental Impact Assessment (Draft for Comments) Supplementary …

07-07

Jul 07, 2021 (AB Digital via COMTEX) -- Recently, another piece of good news comes from the Chinese bio-enzyme API industry. The first batch of thyroid API produced by Sichuan Deeb…
‍Jul 07, 2021 (AB Digital via COMTEX) -- Recently, another piece of good news comes from the Chinese bio-enzyme API industry. The first batch of thyroid API produced by Sichuan Deeb…‍
‍Sichuan Deebio Pharmaceutical Co., Ltd accepted the official GMP compliance inspection from Japan PMDA from 8.25 to 8.26 in 2022. The GMP audit team consisted of two auditors led b…‍

NEWS



Internet Pharmaceutical Information Service

Qualification Certificate Certificate No.: (Chuan) - Non-commercial - 2023-0033

Sichuan ICP Filing No. 13015778-1  

This website does not publish information on narcotic drugs, psychotropic substances, toxic drugs for medical use, radioactive drugs, drug detoxification products, or pharmaceutical preparations for medical institutions.

Add.:

No. 1, East Section of Industrial Avenue, Xiaohan Town, Guanghan City, Sichuan Province, China

Tel:

Domestic Sales :0086-838-5702999

International Sales :0086-838-5703006

Company Switchboard :0086-838-5703009

Mail:

info@deebio.com